[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology 卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
507发布了新的文献求助10
刚刚
李爱国应助陈啊炳采纳,获得10
1秒前
隐形曼青应助高高元柏采纳,获得10
1秒前
2秒前
3秒前
Junanne完成签到,获得积分10
3秒前
Singularity应助林强采纳,获得20
4秒前
angel完成签到,获得积分20
6秒前
有魅力荟发布了新的文献求助10
8秒前
8秒前
9秒前
胡图图完成签到,获得积分10
9秒前
脑洞疼应助Lin采纳,获得10
11秒前
刘敏小七完成签到,获得积分10
12秒前
13秒前
Miller完成签到,获得积分0
13秒前
14秒前
好事花生发布了新的文献求助10
15秒前
15秒前
wllllll发布了新的文献求助10
19秒前
好事花生完成签到,获得积分10
21秒前
李健应助吕zy采纳,获得10
23秒前
丁丁丁完成签到,获得积分10
24秒前
Ava应助有魅力荟采纳,获得10
25秒前
Aura完成签到,获得积分10
25秒前
25秒前
五六七完成签到 ,获得积分10
28秒前
竹筏过海应助楠小秾采纳,获得30
28秒前
CodeCraft应助tym采纳,获得10
28秒前
29秒前
ning完成签到,获得积分10
29秒前
科目三应助tian采纳,获得10
30秒前
30秒前
NancyDee完成签到,获得积分10
30秒前
笨笨完成签到,获得积分10
31秒前
追寻绮烟完成签到,获得积分10
32秒前
大模型应助di采纳,获得30
32秒前
Zzz完成签到 ,获得积分10
33秒前
斯文的橙子给斯文的橙子的求助进行了留言
33秒前
2331547774完成签到,获得积分20
35秒前
高分求助中
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
Mantodea of the World: Species Catalog Andrew M 500
海南省蛇咬伤流行病学特征与预后影响因素分析 500
Neuromuscular and Electrodiagnostic Medicine Board Review 500
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3464150
求助须知:如何正确求助?哪些是违规求助? 3057458
关于积分的说明 9057265
捐赠科研通 2747504
什么是DOI,文献DOI怎么找? 1507379
科研通“疑难数据库(出版商)”最低求助积分说明 696507
邀请新用户注册赠送积分活动 696062